The characteristics and intervention of microvascular abnormality in non-ST segment elevated myocardial infarction after PCI

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900026684

Enrollment

Unknown

Registered

2019-10-18

Start date

2019-10-18

Completion date

Unknown

Last updated

2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-ST segment elevated myocardial infarction

Interventions

control group:Normal saline

experimental group:Eptifibatide

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria include clinical diagnosed NSTEMI with planned PCI and informed consent for participation in the trial, aged 18 to 75 years.

Exclusion criteria

Exclusion criteria: The exclusion criteria include any contraindication of eptifibatide administration and pregnancy.

Design outcomes

Primary

Measure	Time frame
Corrected TIMI Frame Count;major adverse cardiac events (MACE);	—

Secondary

Measure	Time frame
the contrast score index assessed by myocardial contrast echocardiography (MCE);TIMI flow grade;	—

Countries

China

Contacts

Public ContactShijie You

Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences

youshijie6001@aliyun.com+86 13601200351

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026